BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) Act was enacted in 2012. This marks an important milestone for our young and quickly growing industry, culminating in $25 billion raised by promising companies developing potentially life-saving medical advances.